CXCL1 and breast carcinoma: The following in vivo study further demonstrated that TAM co-injection with 4T1 cells significantly promoted breast cancer growth and metastasis, while CXCL1 silencing in TAMs remarkably inhibited the process (Fig. 2F–G).